VTv Total Debt To Capitalization from 2010 to 2024

VTVT Stock  USD 24.04  0.70  2.83%   
VTv Therapeutics Total Debt To Capitalization yearly trend continues to be comparatively stable with very little volatility. Total Debt To Capitalization will likely drop to -0.02 in 2024. From the period from 2010 to 2024, VTv Therapeutics Total Debt To Capitalization quarterly data regression had r-value of  0.71 and coefficient of variation of (97.30). View All Fundamentals
 
Total Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
(0.02)
Current Value
(0.02)
Quarterly Volatility
0.15323654
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many exotic indicators such as Price To Sales Ratio of 26.88, Dividend Yield of 0.0154 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
  
This module can also supplement various VTv Therapeutics Technical models . Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Total Debt To Capitalization Growth Pattern

Below is the plot of the Total Debt To Capitalization of vTv Therapeutics over the last few years. It is VTv Therapeutics' Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization10 Years Trend
Slightly volatile
   Total Debt To Capitalization   
       Timeline  

VTv Total Debt To Capitalization Regression Statistics

Arithmetic Mean(0.16)
Geometric Mean0.1
Coefficient Of Variation(97.30)
Mean Deviation0.13
Median(0.11)
Standard Deviation0.15
Sample Variance0.02
Range0.4185
R-Value0.71
Mean Square Error0.01
R-Squared0.50
Significance0
Slope0.02
Total Sum of Squares0.33

VTv Total Debt To Capitalization History

2024 -0.023
2023 -0.0219
2022 -0.0714
2021 -0.11
2020 -0.0116
2019 -0.17
2018 -0.23

About VTv Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include VTv Therapeutics income statement, its balance sheet, and the statement of cash flows. VTv Therapeutics investors use historical funamental indicators, such as VTv Therapeutics's Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may use each financial statement separately, they are all related. The changes in VTv Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VTv Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VTv Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VTv Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Debt To Capitalization(0.02)(0.02)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:
Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for VTv Stock analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.71)
Revenue Per Share
0.004
Return On Assets
(0.72)
Return On Equity
(49.78)
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.